Loading…
Reported covered position: Assistant Secretary for Legislation, U.S. Department of Health and Human Services
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2026 · second_quarter · 2T
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Source: Senate LDA
2026 · first_quarter · Q1
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2025 · fourth_quarter · Q4
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2025 · third_quarter · Q3
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2025 · second_quarter · Q2
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions.
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions.
Filing targets: Health & Human Services, Dept of (HHS)
2025 · second_quarter · RR
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions.
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions.